Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:neostigmine
|
| gptkbp:ATCCode |
gptkb:N07AA01
|
| gptkbp:CASNumber |
55-60-5
|
| gptkbp:chemicalFormula |
C13H22N2O6S
|
| gptkbp:contraindication |
urinary tract obstruction
mechanical intestinal obstruction |
| gptkbp:eliminationHalfLife |
50-90 minutes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Neostigmine methylsulfate
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
gptkb:acetylcholinesterase_inhibitor
|
| gptkbp:molecularWeight |
342.39 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
nausea
vomiting bradycardia increased salivation |
| gptkbp:usedFor |
gptkb:myasthenia_gravis
reversal of non-depolarizing neuromuscular blockade |
| gptkbp:bfsParent |
gptkb:neostigmine
|
| gptkbp:bfsLayer |
7
|